文献速递临床试验与 GCP流行病学与生物统计

孕前生活方式干预减少妊娠期糖尿病复发的随机对照试验方案

Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional.
PubMed 文献 · Trials · 2021-04-07

该随机对照试验旨在确定孕前减重的生活方式干预能否减少妊娠期糖尿病(GDM)复发,计划招募252名有GDM史且超重或肥胖、计划1–3年内再次妊娠的女性,随机分为综合孕前生活方式干预组或教育对照组,主要结局为GDM复发。

要点

  • 孕前生活方式干预可能减少GDM复发,尚待本试验验证。
  • 试验纳入有GDM史且超重或肥胖、计划再次妊娠的女性。
  • 主要结局为GDM复发,次要结局包括空腹血糖和心血管代谢生物标志物等。

核心结论

  • 这是首个评估孕前生活方式干预预防GDM复发的随机对照试验,若有效可推动治疗实践向围受孕期转移。

研究设计与样本

  • 两中心随机对照试验,目标招募252名有GDM史、超重或肥胖、计划1–3年内再次妊娠的女性。
  • 参与者按中心随机分为综合孕前生活方式干预组(促进减重,持续治疗至受孕)或教育对照组。

主要发现

  • 原文未报告试验结果,仅描述研究方案。

关键数值与推荐

  • 主要结局为GDM复发。
  • 次要结局包括空腹血糖、心血管代谢疾病生物标志物、产前和围产期并发症以及体重、饮食、体力活动和心理社会指标的随时间变化。
  • 评估时间点包括孕前(研究 entry、4个月后及每季度简短访视直至受孕)、妊娠26周和产后6周。

临床怎么用

  • 若干预有效,可为孕前咨询提供证据,优化生殖结局并预防GDM及相关健康风险。

局限性

  • 原文未报告试验结果,无法评估干预效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gestational diabetes mellitus (GDM) is associated with several maternal complications in pregnancy, including preeclampsia, preterm labor, need for induction of labor, and cesarean delivery as well as increased long-term risks of type 2 diabetes, metabolic syndrome, and cardiovascular disease. Intrauterine exposure to GDM raises the risk for complications in offspring as well, including stillbirth, macrosomia, and birth trauma, and long-term risk of metabolic disease. One of the strongest risk factors for GDM is the occurrence of GDM in a prior pregnancy. Preliminary data from epidemiologic and bariatric surgery studies suggest that reducing body weight before pregnancy can prevent the development of GDM, but no adequately powered trial has tested the effects of a maternal lifestyle intervention before pregnancy to reduce body weight and prevent GDM recurrence. METHODS: The principal aim of the Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional is to determine whether a lifestyle intervention to reduce body weight before pregnancy can reduce GDM recurrence. This two-site trial targets recruitment of 252 women with overweight and obesity who have previous histories of GDM and who plan to have another pregnancy in the next 1-3 years. Women are randomized within site to a comprehensive pre-pregnancy lifestyle intervention to promote weight loss with ongoing treatment until conception or an educational control group. Participants are assessed preconceptionally (at study entry, after 4 months, and at brief quarterly visits until conception), during pregnancy (at 26 weeks' gestation), and at 6 weeks postpartum. The primary outcome is GDM recurrence, and secondary outcomes include fasting glucose, biomarkers of cardiometabolic disease, prenatal and perinatal complications, and changes over time in weight, diet, physical activity, and psychosocial measures. DISCUSSION: The Gestational Diabetes Prevention /Prevención de la Diabetes Gestacional is the first randomized controlled trial to evaluate the effects of a lifestyle intervention delivered before pregnancy to prevent GDM recurrence. If found effective, the proposed lifestyle intervention could lay the groundwork for shifting current treatment practices towards the interconception period and provide evidence-based preconception counseling to optimize reproductive outcomes and prevent GDM and associated health risks. TRIAL REGISTRATION: ClinicalTrials.gov NCT02763150 . Registered on May 5, 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Phelan S, Jelalian E, Coustan D, et al. Protocol for a randomized controlled trial of pre-pregnancy lifestyle intervention to reduce recurrence of gestational diabetes: Gestational Diabetes Prevention/Prevención de la Diabetes Gestacional. Trials. 2021. PMID: 33827659. doi:10.1186/s13063-021-05204-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。